247 related articles for article (PubMed ID: 37301197)
1. Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers.
Luo W; Zeng Z; Jin Y; Yang L; Fan T; Wang Z; Pan Y; Yang Y; Yao M; Li Y; Xiao X; Wang G; Wang C; Chang S; Che G; Zhang L; Li Y; Peng Y; Li W
Cell Rep Med; 2023 Jun; 4(6):101078. PubMed ID: 37301197
[TBL] [Abstract][Full Text] [Related]
2. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
Devarakonda S; Li Y; Martins Rodrigues F; Sankararaman S; Kadara H; Goparaju C; Lanc I; Pepin K; Waqar SN; Morgensztern D; Ward J; Masood A; Fulton R; Fulton L; Gillette MA; Satpathy S; Carr SA; Wistuba I; Pass H; Wilson RK; Ding L; Govindan R
J Clin Oncol; 2021 Nov; 39(33):3747-3758. PubMed ID: 34591593
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma.
Cha YJ; Kim EY; Choi YJ; Kim CY; Park MK; Chang YS
Front Immunol; 2023; 14():1154881. PubMed ID: 37435086
[TBL] [Abstract][Full Text] [Related]
5. Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma.
Li D; Yu H; Hu J; Li S; Yan Y; Li S; Sun L; Jiang G; Hou L; Zhang L; Zhang P
J Transl Med; 2022 Sep; 20(1):423. PubMed ID: 36138435
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Waterpipe Smoke-Induced Lung Tumor Autophagy and Plasticity.
Zaarour RF; Sharda M; Azakir B; Hassan Venkatesh G; Abou Khouzam R; Rifath A; Nizami ZN; Abdullah F; Mohammad F; Karaali H; Nawafleh H; Elsayed Y; Chouaib S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743294
[TBL] [Abstract][Full Text] [Related]
7. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Jung J; Lee YJ; Kim CH; Ahn S
PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy.
de Alencar VTL; Figueiredo AB; Corassa M; Gollob KJ; Cordeiro de Lima VC
Front Immunol; 2022; 13():984349. PubMed ID: 36091058
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
Luo W; Tian P; Wang Y; Xu H; Chen L; Tang C; Shu Y; Zhang S; Wang Z; Zhang J; Zhang L; Jiang L; Liu L; Che G; Guo C; Zhang H; Wang J; Li W
Int J Cancer; 2018 Oct; 143(7):1696-1705. PubMed ID: 29667179
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
12. Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments.
Li X; Li J; Wu P; Zhou L; Lu B; Ying K; Chen E; Lu Y; Liu P
Oncoimmunology; 2018; 7(10):e1494677. PubMed ID: 30288364
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.
Pros E; Saigi M; Alameda D; Gomez-Mariano G; Martinez-Delgado B; Alburquerque-Bejar JJ; Carretero J; Tonda R; Esteve-Codina A; Catala I; Palmero R; Jove M; Lazaro C; Patiño-Garcia A; Gil-Bazo I; Verdura S; Teulé A; Torres-Lanzas J; Sidransky D; Reguart N; Pio R; Juan-Vidal O; Nadal E; Felip E; Montuenga LM; Sanchez-Cespedes M
Ann Oncol; 2020 Feb; 31(2):274-282. PubMed ID: 31959344
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
Seike M; Goto A; Okano T; Bowman ED; Schetter AJ; Horikawa I; Mathe EA; Jen J; Yang P; Sugimura H; Gemma A; Kudoh S; Croce CM; Harris CC
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12085-90. PubMed ID: 19597153
[TBL] [Abstract][Full Text] [Related]
15. A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers.
Hamouz M; Hammouz RY; Bajwa MA; Alsayed AW; Orzechowska M; Bednarek AK
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686122
[TBL] [Abstract][Full Text] [Related]
16. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
18. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer in never smokers.
Torok S; Hegedus B; Laszlo V; Hoda MA; Ghanim B; Berger W; Klepetko W; Dome B; Ostoros G
Future Oncol; 2011 Oct; 7(10):1195-211. PubMed ID: 21992731
[TBL] [Abstract][Full Text] [Related]
20. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
